Streetbeat News

Stock Prices

CPRX

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported Q1 adjusted earnings of $0.38 per share, surpassing the $0.17 estimate, a 123.53% beat. Despite a 7.32% decrease from last year's $0.41, sales rose to $98.51M, slightly above the $98.13M forecast, marking a 15.40% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:22 pm

PRTA

Prothena Corp (NASDAQ:PRTA) reported Q1 2024 GAAP EPS of $(1.34), missing the $(1.20) estimate, with sales of $900.00K also missing the $2.17M estimate, a 58.51% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:22 pm

CYN

Cyngn (NASDAQ:CYN) reported Q1 2024 earnings with a GAAP EPS of $(0.08), surpassing the $(0.13) estimate, indicating a 38.46% beat and a 46.67% improvement from last year's $(0.15) per share. However, their sales of $5.513K drastically missed the $360K estimate by 98.47%, showcasing a significant 99.37% decline from the previous year's $872.8K.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:22 pm

PETQ

PetIQ reported Q1 2024 adjusted EPS of $0.58, surpassing the $0.43 estimate, and sales of $308.443M, exceeding the $300.493M forecast. This represents a 28.89% increase in EPS and a 6.19% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:21 pm

ABNB

Airbnb Inc (NASDAQ:ABNB) reported Q1 earnings with an 18% year-over-year revenue increase to $2.14 billion, surpassing the consensus estimate of $2.06 billion. Earnings per share were 41 cents, beating the 22 cents estimate. Gross booking value rose 12% to $22.9 billion, and nights and experiences booked increased by 9.5% to 132.6 million. The company ended the quarter with $11.1 billion in cash and equivalents. Airbnb forecasts Q2 revenue between $2.68 billion and $2.74 billion, expecting stable growth in nights booked. The company anticipates a stronger revenue growth in Q3 2024 due to robust summer travel demand. After the report, ABNB shares dropped 7.75% in after-hours trading to $146.34.

Portfolio Pulse from Adam Eckert

May 08, 2024 | 8:21 pm

SNEX

StoneX Group Inc. (SNEX) reported Q2 2024 adjusted earnings per share (EPS) of $1.63, surpassing the consensus estimate of $1.56 by 4.49%. Quarterly sales reached $818.2 million, exceeding expectations of $402.682 million by 103.19% and marking a 16.16% increase from the previous year's $704.4 million.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:20 pm

ALTG

Alta Equipment Group (NYSE:ALTG) reported Q1 adjusted losses of $(0.22) per share, missing the $(0.20) estimate by 10%, and a 650% decrease from last year's earnings. However, their sales of $441.60M exceeded the $420.40M estimate by 5.04%, marking a 4.97% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:20 pm

HLI

Houlihan Lokey (NYSE:HLI) exceeded Q4 earnings and sales forecasts, reporting earnings of $1.27 per share and sales of $520.46M, surpassing estimates of $1.23 per share and $508.99M, respectively. This represents a 14.41% increase in earnings and a 17.02% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:20 pm

UTI

Universal Technical (NYSE:UTI) reported Q2 2024 earnings of $0.14 per share, missing the consensus estimate of $0.15 by 6.67%. However, their sales of $184.176M exceeded estimates by 3.96%, marking a 12.43% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:20 pm

FSK

FS KKR Capital (FSK) reported Q1 2024 adjusted EPS of $0.76, surpassing the $0.71 estimate, with sales of $434M beating the $428.564M estimate, a 4.82% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 8:20 pm